EP951 - ECE_3328 - Targeting the inflammasome machinery: a multi-omic approach to identify new diagnostic markers and therapeutic strategies in brain tumors
The expression of key inflammasome components (highlighting MYD88) correlated significantly with aggressive clinical parameters and poor prognosis, including reduced survival rates, higher recurrence, EGFR amplification, and MGMT promoter methylation status.